Organogenesis Holdings Inc.Financials
|
|
Historical Financials
DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 | DEC 2020 | DEC 2019 | DEC 2018 | DEC 2017 | DEC 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 564,169,000 | 482,043,000 | 433,140,000 | 450,893,000 | 467,359,000 | 338,298,000 | 260,981,000 | 193,449,000 | 198,508,000 | 138,732,000 | |
| Cost of Revenue | - | 115,741,000 | 106,481,000 | 105,019,000 | 114,199,000 | 87,319,000 | 75,948,000 | 68,808,000 | 61,220,000 | 48,201,000 | |
| Gross Profit | - | 366,302,000 | 326,659,000 | 345,874,000 | 353,160,000 | 250,979,000 | 185,033,000 | 124,641,000 | 137,288,000 | 90,531,000 |
Sign up to view full financial statements
Create a free CapEdge account to access balance sheet, cash flow, and complete historical data.
DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 | DEC 2020 | DEC 2019 | DEC 2018 | DEC 2017 | DEC 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin (%) | |||||||||||
| R&D Expense | |||||||||||
| SG&A Expense | |||||||||||
| Total Operating Expenses | |||||||||||
| Operating Income or Loss | |||||||||||
| Operating Margin (%) | |||||||||||
| EBITDA | |||||||||||
| Interest Expense | |||||||||||
| Non-Operating Income/Expense | |||||||||||
| Income Before Tax | |||||||||||
| Income Tax Expense | |||||||||||
| Income from Continuing Ops. | |||||||||||
| Net Income | |||||||||||
| Net Profit Margin (%) | |||||||||||
| Basic EPS | |||||||||||
| Diluted EPS | |||||||||||
| Basic Average Shares | |||||||||||
| Diluted Average Shares |
All numbers in thousands. Financial statements are in beta and sourced from EDGAR XBRL filings. Read the caveats.